It exerts its effects on neutrophils via two different cell surface receptors initially named as CXCR1 and CXCR2, mediating and regulating leukocyte recruitment and activation at sites of inflammation (46), followed by ischemia, promoting leakage, and neovascularization (47). The gene discussed is CXCR1; the disease is ischemia.